| Literature DB >> 35960109 |
Sheng Huang1, Junlong Zhong1, Qihua Qi1, Gangan Liu1, Ming Gong2.
Abstract
PURPOSE: Circular RNAs (circRNAs) play an critical role in the pathological processes associated with IDD. However, the potential roles of circRNAs in IDD remain largely unclear. Here, we identify the circRNAs expression profiles and elucidate the potential role of candidate circRNAs in the pathogenesis of intervertebral disc degeneration (IDD) through microarray data and bioinformatics analyses.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35960109 PMCID: PMC9371492 DOI: 10.1097/MD.0000000000030035
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
The top 5 upregulated and downregulated circRNAs ranked by fold changes.
| circRNA | log2FC |
| Position | Strand | Sequence length | Best transcript | Gene symbol | Regulation |
|---|---|---|---|---|---|---|---|---|
| hsa_circ_0040039 | 2.953 | <.00001 | chr16:69279504-69318147 | + | 765 | NM_006750 | SNTB2 | Up |
| hsa_circ_0092342 | 2.808 | <.00001 | chr11:8706439-8707219 | + | 780 | NM_000990 | RPL27A | Up |
| hsa_circ_0004354 | 2.799 | <.00001 | chr16:69317950-69318147 | + | 197 | NM_006750 | SNTB2 | Up |
| hsa_circ_0028173 | 2.795 | <.00001 | chr12:110764194-110780253 | + | 1774 | NM_170665 | ATP2A2 | Up |
| hsa_circ_0047151 | 2.760 | <.00001 | chr18:21001330-21010641 | – | 125 | NM_032933 | TMEM241 | Up |
| hsa_circ_0082686 | –3.319 | <.00001 | chr7:139741443-139746807 | – | 320 | NM_022750 | PARP12 | Down |
| hsa_circ_0036763 | –3.318 | <.00001 | chr15:90760670-90763123 | + | 326 | NM_020210 | SEMA4B | Down |
| hsa_circ_0003258 | –3.179 | <.00001 | chr17:47388673-47389404 | – | 261 | NM_001145365 | ZNF652 | Down |
| hsa_circ_0003183 | –3.089 | <.00001 | chr8:61496766-61504528 | + | 288 | NM_002865 | RAB2A | Down |
| hsa_circ_0072464 | –3.086 | <.00001 | chr5:53409031-53450469 | – | 269 | NM_019087 | ARL15 | Down |
Figure 1.The expression profiles of circRNAs and their parental gene distribution in chromosomes. (A) Hierarchical clustering analysis showed 104 differentially expressed circRNAs (|log2 fold change| > 2, P < .05) between the IDD group and the control group. The red color represents the upregulated circRNAs and the green color represents the downregulated circRNAs. (B) Volcano plot of differentially expressed circRNAs (|log2 fold change| > 2, P < .05). The red plots represent the upregulated circRNAs with log2 (fold change) > 2, P < .05. The green plots represent the downregulated circRNAs with log2 (fold change) < –2, P < .05. logFC: log2 fold change. (C) The distribution of the parental genes of differentially expressed circRNAs in human chromosomes. IDD = intervertebral disc degeneration.
Figure 2.Venn diagrams of overlapping miRNAs and potential binding sites of hsa_circ_0040039 on hsa-miR-424-5p and hsa-miR-15b-5p. (A) The Venn diagrams show that 4 overlapping miRNAs were identified from the downregulated miRNAs and predicted target miRNAs (predicted from RegRNA 2.0 and starBase 3.0) of hsa_circ_0040039. (B) Three potential binding sites common to hsa_circ_0040039 and has-miR-15b-5p (obtained from starBase 3.0). (C) Three potential binding sites common to hsa_circ_0040039 and has-miR-424-5p (obtained from starBase 3.0).
Figure 3.circRNA-miRNA-mRNA regulatory network. This network is composed of 1 circRNA (yellow octagon), 2 target miRNAs (purple tetragons), and 77 indirect target mRNAs (cyan nodes).
Figure 4.GO and KEGG analyses of 77 target mRNAs. The length of the column represents the number of mRNAs. The color of the column represents the adjusted P value. Red: high-level enrichment; blue: low-level enrichment. (A) The top 15 significantly enriched GO terms. (B) The 7 significantly enriched KEGG signaling pathways. GO = gene ontology; KEGG = Kyoto Encyclopedia of Genes and Genomes.
The top 15 enriched GO terms of target mRNAs.
| ID | Term | Gene symbol | Count |
|
|---|---|---|---|---|
| GO:0046332 | SMAD binding | ACVR2A, AXIN2, FKBP1A, SKI, SMAD3, TGFBR3 | 6 | 9.64E-07 |
| GO:0019199 | Transmembrane receptor protein kinase activity | ACVR2A, FGFR1, INSR, KDR, TGFBR3 | 5 | 2.12E-05 |
| GO:0008013 | Beta-catenin binding | AXIN2, BTRC, CARM1, SMAD3, TBL1XR1 | 5 | 2.25E-05 |
| GO:0031625 | Ubiquitin protein ligase binding | ATF6, AXIN2, BAG4, CUL2, GABARAPL1, PRKAR2A, SKI, SMAD3 | 8 | 2.34E-05 |
| GO:0048185 | Activin binding | ACVR2A, FKBP1A, TGFBR3 | 3 | 2.40E-05 |
| GO:0044389 | Ubiquitin-like protein ligase binding | ATF6, AXIN2, BAG4, CUL2, GABARAPL1, PRKAR2A, SKI, SMAD3 | 8 | 3.37E-05 |
| GO:0005160 | Transforming growth factor beta receptor binding | ACVR2A, FKBP1A, SMAD3, TGFBR3 | 4 | 5.83E-05 |
| GO:0004713 | Protein tyrosine kinase activity | FGF2, FGFR1, INSR, KDR, MAP2K3, WEE1 | 6 | 9.17E-05 |
| GO:0004674 | Protein serine/threonine kinase activity | ACVR2A, AKT3, CASK, CHEK1, MAP2K3, STK38, TAOK1, TGFBR3, WNK3 | 9 | .000105 |
| GO:0061630 | Ubiquitin protein ligase activity | BTRC, COP1, CUL2, SIAH1, ZNRF2, ZNRF3 | 6 | .000221 |
| GO:0061659 | ubiquitin-like protein ligase activity | BTRC, COP1, CUL2, SIAH1, ZNRF2, ZNRF3 | 6 | .000251 |
| GO:0019838 | Growth factor binding | ACVR2A, FGFR1, INSR, KDR, TGFBR3 | 5 | .000259 |
| GO:0034713 | Type I transforming growth factor beta receptor binding | ACVR2A, FABP1A | 2 | .000908 |
| GO:0004842 | Ubiquitin protein transferase activity | BTRC, COP1, CUL2, SIAH1, UBE2V1, ZNRF2, ZNRF3 | 7 | .001246 |
| GO:0005024 | Transforming growth factor beta-activated receptor activity | ACVR2A, TGFBR3 | 2 | .001714 |
The 7 enriched KEGG signaling pathways of target mRNAs.
| Pathway ID | Pathway name | Gene symbol | Count |
|
|---|---|---|---|---|
| hsa04550 | Signaling pathways regulating pluripotency of stem cells | ACVR2A, AKT3, AXIN2, FGF2, FGFR1, SMAD3 | 6 | 8.61E-05 |
| hsa04310 | Wnt signaling pathway | AXIN2, BTRC, SIAH1, SMAD3, TBL1XR1, ZNRF3 | 6 | .000175 |
| hsa04115 | p53 signaling pathway | CHEK1, COP1, SIAH1, ZMAT3 | 4 | .000560 |
| hsa04015 | Rap1 signaling pathway | AKT3, FGF2, FGFR1, INSR, KDR, MAP2K3 | 6 | .000725 |
| hsa04010 | MAPK signaling pathway | AKT3, FGF2, FGFR1, INSR, KDR, MAP2K3, TAOK1 | 7 | .000859 |
| hsa04014 | Ras signaling pathway | AKT3, FGF2, FGFR1, INSR, KDR, SHOC2 | 6 | .001346 |
| hsa04218 | Cellular senescence | AKT3, BTRC, CHEK1, MAP2K3, SMAD3 | 5 | .001531 |
Figure 5.PPI network analysis of the target mRNAs. An interaction score of 0.7 (high confidence) was regarded as the cutoff criterion, and the disconnected nodes in the network were hidden. (A) PPI network of target mRNAs. (B) The number of connected nodes for the top 15 genes. PPI = protein-protein interaction.